Australia, Oct. 15 -- Iambic Therapeutics Inc., owns the trademark (2516238) for 'ENCHANT' till Jan. 23, 2035.
Status: registered:
Registered/protected
Class: 42 [Technical scientific consultation and product development for others in the fields of science, (excluding software and computer sciences), chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry (excluding software and computer sciences), chemical engineering, medicine, and healthcare; development of materials, chemicals, and pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; research and development of treatment p...